Stopping smoking reduces risk of stroke in the elderly

Quitting smoking reduces the risk of heart attack and stroke during moments of great stress and also in old age says a study released today by the German Center for Cancer Research (DKFZ). A smoker of 60 years has many risks of heart attack as opposed to a 19 years-old man non-smoker. 

Still, those who cease smoking in old age can also have positive results soon. This was the conclusion of a study of eight thousand inhabitants of the German state of Sarre. The positive effects of quitting smoking can be observed almost immediately, the risk of heart attacks and strokes after five years are reduced by 40%.

SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...